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Abstract: The depletion of limbal stem cells due to various diseases leads to corneal 
opaciﬁ  cation and visual loss. The unequivocal identiﬁ  cation and isolation of limbal stem cells 
may be a considerable advantage because long-term, functional recovery of corneal epithelium 
is linked to graft constructs that retain viable stem cell populations. As speciﬁ  c markers of 
limbal stem cells, the ATP-binding cassette, sub-family G, member2 (ABCG2), a member 
of the multiple drug-resistance (MDR) family of membrane transporters which leads to a side 
population phenotype, and transcription factor p63 were proposed recently. Conventional 
corneal transplantation is not applicable for patients with limbal stem cells deﬁ  ciency, because 
the conventional allograft lacks limbal stem cells. The introduction of limbal epithelial cell 
transplantation was a major advance in the therapeutic techniques for reconstruction of the corneal 
surface. Limbal epithelial cell transplantation is clinically conducted when cultured allografts as 
well as autografts are available; however, allografts have a risk of immunologic rejection and 
autografts are hardly available for patients with bilateral ocular surface disorders. Embryonic 
stem (ES) cells are characterized by their capacity to proliferate indeﬁ  nitely and to differentiate 
into any cell type. We induced corneal epithelial cells from ES cells by culturing them on type IV 
collagen or alternatively, by introduction of the pax6 gene into ES cells. Recent advances in 
our study supports the possibility of their clinical use as a cell source for reconstruction of the 
damaged corneal surface. This review summarizes the recent advances in corneal regeneration 
therapies and the possible application of ES cell-derived corneal epithelial cells.
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Introduction
Limbal stem cell deﬁ  ciencies cause conjunctival epithelial ingrowth, neovascularization, 
chronic inﬂ  ammation, recurrent epithelial erosions and defects, destruction of the 
basement membrane, and ﬁ  brous tissue ingrowth, leading to severe functional 
impairment (Tsai et al 1990; Tsubota et al 1995; Kruse and Reinhard 2001). The 
pathology includes Stevens-Johnson syndrome, ocular cicatricial pemphigoid, 
chemicals and thermal burns and radiation injury.
Proper visual function requires an intact ocular surface. The integrity of the corneal 
surface is maintained by two specialized epithelia, the conjunctival epithelium and 
the limbal corneal epithelium. Corneal epithelial stem cells reside in the palisades of 
Vogt, located in the basal layer of the limbus, coinciding with the transitional zone 
between the cornea and the bulbar conjunctiva (Schermer et al 1986; Cotsarelis et al 
1989). Limbal stem cells produce undifferentiated progeny with limited proliferative 
potential that migrate centripetally from the periphery of the corneal epithelium to 
replace cells desquamating during normal cell turnover (Kinoshita et al 1981; Buck 
1985; Kruse 1994; Beebe and Masters 1996; Lehrer et al 1998; Collinson et al 2003; 
Nagasaki and Zhao 2003).Clinical Ophthalmology 2007:1(4) 374
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Conventional corneal transplantation, which replaces 
the central part of the cornea with the same part from a 
donor cornea, is used to treat diseases such as keratoco-
nus with intact limbal stem cells; however, conventional 
corneal transplantation is not applicable for patients with 
limbal stem cell deficiency. In those cases, the donor cor-
nea is rejected and the cornea is covered by cells migrating 
from the recipient’s conjunctival epithelium. A series 
of events leads to functional blindness. To prevent this 
conjunctival invasion of the corneal surface, restoration 
of the limbus is required. Recently, corneal regeneration 
therapy made dramatic progress and is already in clini-
cal practice.
In this article, we summarize recent advances in corneal 
regeneration therapies and report the possible application of 
epithelial cells derived from embryonic stem (ES) cells for 
surface reconstruction of the damaged cornea.
Efforts to identify corneal epithelial 
stem cells
The integrity of the ocular surface is maintained by the 
centripetal migration of transient amplifying cells derived 
from limbal stem cells. Transient amplifying cells are 
present in the corneal epithelia and are committed to 
epithelial differentiation with limited proliferative potential 
(Figure 1). The rapidly proliferating transient amplifying 
cells undergo terminal differentiation accompanied by loss 
of their proliferative potential.
Limbal stem cells are normally slow cycling cells. When 
activated by wounding or by in vitro culture conditions, they 
grow and regenerate the tissue with high proliferative potential 
(Thoft and Friend 1983; Buck 1985; Cotsarelis et al 1989). Lim-
bal stem cells lack corneal epithelial differentiation-associated 
markers, such as cytokeratin 3 (Schermer et al 1986), and have 
highly mitotic ability in vitro (Ebato et al 1987).
Cytokeratins are intermediate filamentous proteins 
expressed by epithelial cells. A large number of cytokeratin 
proteins have been identiﬁ  ed, each with a speciﬁ  c expression 
pattern in different epithelial cells. Cytokeratin 12 and 
cytokeratin 3 are expressed in differentiated and stratiﬁ  ed 
corneal epithelium, although the relative expression of each 
appears to vary between species. Conjunctiva epithelia 
express mainly cytokeratin 5 and cytokeratin 14 in their basal 
layers. On the ocular surface, it is important to distinguish 
the corneal epithelia from conjunctival epithelia, because, 
during the healing of corneal epithelial wounds with limbal 
paslisades of Vogt
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Figure 1 Schematic representation of corneal epithelial cells. The ocular surface is composed of three epithela, conjunctival, limbal and corneal. Limbal stem cells are 
located in the palisades of Vogt, the transitional zone between the cornea and the conjunctiva. Limbal stem cells are close to blood vessels. They generate transient 
amplifying cells that terminally differentiate after a discrete number of cell divisions to corneal epithelial cells and undergo both centripetal migration and vertical migration.Clinical Ophthalmology 2007:1(4) 375
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cell deﬁ  ciency, conjunctival epithelium often migrates across 
the denuded limbus to cover the corneal surface (Shapiro 
et al 1981; Tsai et al 1990; Dua 1998), causing a pronounced 
decrease in visual acuity.
Speciﬁ  c markers for limbal stem cells have not been 
identiﬁ  ed. Recently, many types of tissue-speciﬁ  c stem cells 
have been shown to exhibit a side population phenotype, 
deﬁ  ned by their unique ability to efﬂ  ux the DNA bind-
ing dye Hoechst 33342 (Goodell et al 1997; Storms et al 
2000). Side population cells are small size and exclude 
Hoechst 33342 dye with blue and red ﬂ  uorescence from 
the cell body. Thus, side population cells lack blue and red 
ﬂ  uorescence when analyzed by ﬂ  ow cytometer (Figure 2). 
The side population phenotype is largely determined by 
expression of the ATP-binding cassette, sub-family G, 
and member2 (ABCG2), a member of the multiple drug 
resistance (MDR) family of membrane transporters (Zhou 
et al 2001; Lechner et al 2002). ABCG2 is reported to 
contribute to the side population phenotype in cells from 
various cell sources, including hematopoietic stem cells. 
Using ﬂ  uorescence-activated cell sorting with Hoechst 
33342 dye staining, approximately 0.3%–0.5% of limbal 
epithelial cells exhibit the side population phenotype in 
humans, whereas no side population cells have been iden-
tiﬁ  ed in the central corneal epithelium (Watanabe et al 
2004, Wolosin et al 2004); therefore, it was suggested that 
ABCG2-positive limbal epithelial cells may include puta-
tive limbal stem cells (Watanabe et al 2004).
Transcription factor p63 is a member of the p53 
family, and is essential for epithelial development and 
differentiation. p63 has been considered a potential marker 
of stem/progenitor cells in ocular tissue (Pellegrini et al 
2001). It has been hypothesized that p63 may be an earlier 
marker of limbal stem cells. p63 is highly expressed in the 
nuclei of limbal basal cells but not in the corneal epithelium 
(Parsa et al 1999). In addition, it has been demonstrated 
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Figure 2 Schematic representation of the side population cells analyzed by ﬂ  ow cytometry. Rat limbal stem cells were treated with Hoechst 33342 dye and were analyzed 
by ﬂ  ow cytometry. A population of cells with low Hoechst 33342 blue/red ﬂ  uorescence was isolated as side population cells in the limbus. Non-side population cells 
accompanying high Hoechst 33342 blue/red ﬂ  uorescence formed a distinct cell population.Clinical Ophthalmology 2007:1(4) 376
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that p63 expression is gradually reduced from basal cells 
to terminally differentiated corneal epithelial cells (De et al 
2000; Pellegrini et al 2001). These ﬁ  ndings suggested that 
p63-positive cells may include limbal stem cells. In any 
event, the identiﬁ  cation and isolation of limbal stem cells 
may contribute largely to reconstruction of the ocular sur-
face because long-term, functional recovery of the corneal 
epithelium is linked to graft constructs that retain viable stem 
cell populations.
Development of corneal 
regeneration therapies
Several ophthalmologists have succeeded in the clinical 
transplantation of grafts generated from expanded limbal 
stem cells to treat patients with limbal stem cell deﬁ  ciencies 
(Pellegrini et al 1997; Tsai et al 2000; Koizumi et al 2001; 
Rama et al 2001; Nishida 2003). The methods involve the 
following two major approaches, allograft transplantation 
and autologous limbal transplantation (Figure 3).
Allograft transplantation is performed in patients with 
unilateral or bilateral deﬁ  ciencies (Koizumi et al 2001). 
The limbal stem cells obtained by biopsy were forced 
to proliferate sufﬁ  ciently in the ex vivo culture and the 
cell sheet made of the expanded limbal stem cells was 
transplanted to the damaged cornea. Transient amplifying 
cells are supplied continuously from the donor limbus, 
and thus corneal limbal epithelium is formed largely by 
transient amplifying cells in the recipient cornea (Lehrer 
et al 1998; Tsubota et al 1999); however, this procedure 
carries risks of immunologic rejection and infection of 
unidentiﬁ  ed organisms. Graft failure usually occurs, even 
with continuous immunosuppression, owing to serious pre-
operative conditions such as persistent inﬂ  ammation of the 
ocular surface, severe dry eye and lid related abnormalities 
(Solomon et al 2002).
Transplantation of autologous limbal stem cell sources 
is an alternative to allograft transplantation and does not 
require immunosuppression (Pellegrini et al 1997; Nishida 
2003). Autologous limbal transplantation is a method of 
surface reconstruction of the cornea in patients with uni-
lateral total deﬁ  ciency of limbal stem cells (Kenyon and 
Tseng 1989; Tsai and Tseng 1994; Morgan and Murray 
1996); however, this procedure requires a large limbal graft 
from the healthy eye (usually 30%–40% of the donor limbs) 
(Chen and Tseng 1990). Corneal cell sheets used as grafts 
were prepared from ex vivo culture of the autologous limbal 
stem cells; however, grafts lacking a structural basement 
membrane and extracellular matrix system were fragile and 
had problems with the decrease of cell to matrix adhesion. 
Therefore, several researchers have developed autologous 
cultivated corneal epithelial stem cell sheets using the amni-
otic membrane, ﬁ  brin gel and a temperature-sensitive cell 
culture surface as a carrier of the cell sheets. (Tsubota et al 
1996; Holland and Schwartz 1999; Schwab et al 2000; Tsai 
et al 2000; Koizumi et al 2001; Rama et al 2001; Shimazaki 
et al 2004; Nakamura et al 2004; Nishida et al 2004a). These 
procedures use biological materials and synthetic polymers 
to cultivate transplantable sheets. The amniotic membrane 
supports the proliferation and differentiation of limbal stem 
cells (Kim and Tseng 1995). Cells cultured on the amniotic 
membrane showed signiﬁ  cantly reduced vascularization and 
inﬂ  ammation by comparison with other carriers of sheets. 
Immunoreaction may be suppressed by using the amniotic 
membrane, because the amniotic membrane expresses 
incomplete HLA-A, B, C and DR antigens, which may 
account for the fact that immunological rejection after 
transplantation has not been observed in this method (Akle 
et al 1981). Collectively, cells cultured on the amniotic 
membrane are suitable for transplantation and are easy to 
handle. These results revealed that the amniotic membrane 
is applicable as a carrier of corneal epithelial cell sheets. 
This method (autologous cultivated corneal epithelial 
stem cell sheets using the amniotic membrane) can not be 
applied for bilateral total limbal stem cell deﬁ  ciency such 
as Stevens-Johnson and ocular cicatricial pemphigoid. In 
addition, there is a possibility of infection by an unidenti-
ﬁ  ed microorganism.
Recently, autologous epithelial cell sheets were devel-
oped by culturing a patient’s oral mucous membrane on 
temperature-sensitive culture surfaces and were successfully 
transplanted to the damaged cornea (Nishida et al 2004b). 
Temperature-sensitive culture surfaces allow oral mucousal 
epithelial cells to interact directly with a recipient’s ocular 
surface without interference from cell carriers such as ﬁ  brin 
gel and the amniotic membrane. After transplantation and 
adaptation to the recipient’s microenvironment, the grafted 
oral mucosal epithelial cells expressed cytokeratin 3; how-
ever, they did not express cytokeratin 12. These ﬁ  ndings 
suggest that oral mucousal epithelial cells do not differenti-
ate fully to authentic corneal epithelial cells. If oral mucosa 
membranes are damaged in systematic diseases such as 
Stevens-Johnson syndrome, it is hard to recover oral mucosal 
epithelial cells to make cell sheets.
The most important key to realizing the reconstruction is 
a sufﬁ  cient supply of the cells/materials needed for transplan-
tation; therefore, we have focused our attention on ES cells, Clinical Ophthalmology 2007:1(4) 377
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because ES cells proliferate indeﬁ  nitely and may provide sufﬁ  -
cient numbers of epithelial cells for corneal transplantation.
ES cells as a new cell source 
of corneal epithelial cell 
transplantation
Stem cells are the primary cells common to all multi-
cellular organisms that maintain the ability of renewal 
through cell division, and differentiate into a wide range 
of specialized cell types. Recent stem cell researches 
indicated their huge potential as a source of tissue for 
regenerative medicine. Stem cells may be obtained from 
embryonic tissues, umbilical cord blood, and some dif-
ferentiated adult tissues; however, adult stem cells pref-
erentially generate differentiated cells of the same lineage 
as their tissue of origin.
Healthy area 
of petient’s 
cornea
Allogenic 
limbal
epithelium
Autologous
limbal
epithelium
Oral
epithelium
Injury
Culture on fibrin gel,
aminiotic membarane and
temperature sensitive cell culture surface
Sheets of cultured cells
on the damaged cornea
Figure 3 Corneal regeneration by using cell sheets made of cultured corneal epithelial cells. Several cell sources which include limbal stem cells are applicable to form 
epithelial cell sheets for treating patients with limbal stem cell deﬁ  ciencies. Limbal stem cells are obtained from a healthy area of a patient’s injured cornea (autologous lim-
bal epithelium).  Allogeneic limbal epithelium and autologous limbal epithelium of a patient’s contralateral normal cornea are similarly applicable.  After culturing on ﬁ  brin gel, 
the amniotic membrane and a temperature-sensitive cell culture surface, these cells formed cell sheets, which were then transplanted onto the damaged cornea. Successful 
application of a patient’s oral mucous membrane was reported. Oral epithelium is used as an alternative to the limbal epithelium when the patient has severe bilateral limbal 
stem cell deﬁ  ciency.Clinical Ophthalmology 2007:1(4) 378
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The most primitive cell is the fertilized egg. The fertilized 
egg and the descendants of the ﬁ  rst two cell divisions are toti-
potent, and are able to form the embryo and the trophoblasts 
of the placenta. After about four days, these totipotent cells 
begin to differentiate into blastocysts (Figure 4). ES cells are 
cultures of cells derived from epiblast tissue of the inner cell 
mass (ICM) of a blastocyst (Alison et al 2002; Czyz et al 2003). 
ES cells are isolated by transferring the inner cell mass into a 
plastic culture dish that contains a nutrient culture medium. 
After propagation culture, ES cells were established. ES cells 
are pluripotent cells; they have the ability to differentiate into 
any cell type of all three germ layers as ectoderm, mesoderm, 
and endoderm cells, including corneal epithelial progenitors.
ES cells develop into each of the more than 200 cell 
types of the adult body when given sufﬁ  cient and necessary 
stimulation for speciﬁ  c cell-type differentiation (Figure 5). 
When ES cells are given no stimuli for differentiation, they 
continue to divide in vitro for a long time and each daughter 
cell remains pluripotent; therefore, ES cells are a valuable 
cell source for regenerative medicine and tissue replacement 
after injury and disease (Kim and Auerbach 2002; Blyszc-
zuk and Czyz 2003). After transplantation, ES-derived cells 
have the potential to replace host cells lost during injury and 
disease. Alternatively, ES-derived cells supply host tissues 
with therapeutic factors leading to a functional beneﬁ  t. 
Medical researchers who are studying ES cell differentia-
tion anticipate treating a wide variety of diseases including 
leukemia, Parkinson’s disease, spinal cord injuries, and 
muscle damage, amongst a number of other impairments and 
conditions (Lindvall 2003; Goldman and Windrem 2006). 
Mouse ES cells are commonly used in basic research ﬁ  eld, 
because they are easy to transfect with a speciﬁ  c gene and 
perform gene knock out.
In 1998, Dr. Thomson reported the culture of human 
ES cells, and the production of all kinds of cells and tissues 
derived from ES cells for transplantation has logically 
become a reality (Thomson et al 1998); however, ES cell 
research is ethically controversial, because an ES cell line is 
made from an extra fertilized ovum used in infertility therapy. 
Many nations currently have a moratorium on either ES cell 
research or the production of new ES cell lines.
Previously, we have reported induction of the differen-
tiation of mouse ES cells into corneal epithelial progenitor 
cells by culturing them on type IV collagen and successful 
reconstruction of the damaged cornea by transplantation of 
ES cell-derived epithelial progenitor cells (Homma et al 
2004). In general, the presence of substrates or basement 
membranes is necessary to support normal differentiation of 
corneal epithelial cells. Type IV collagen is the basic struc-
tural component of all basement membranes and forms the 
backbone to which other basement membrane components 
attach (Cleutjens et al 1990). The cornea is initially covered 
with an epithelium that attaches to the normal basement 
membrane during eye development (Cleutjens et al 1990); 
egg
sperm cell
A fertilized egg Morula
Culture of ES cells
Inner cell mass
Blastocyst
Figure 4 Establishment of ES cells from fertilized egg. ES cells are derived from embryos developed from eggs that have been fertilized in vitro. Human ES cells are typically 
four or ﬁ  ve days old and are a hollow microscopic ball of cells called a blastocyst. The inner cell mass of the blastocyst is collected and cultured on a feeder cell layer.  After 
several passages, the cells are established as ES cells.Clinical Ophthalmology 2007:1(4) 379
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therefore, we used type IV collagen as a substitution sub-
strate of the basement membrane. Undifferentiated ES cells 
were collected from the maintenance culture consisting of 
leukemia inhibitor factor and mouse embryonic ﬁ  broblasts 
as feeder cells. ES cells were cultured on cell culture dishes 
for four days to make embryoid bodies. The embryoid bodies 
were transferred to dishes coated with type IV collagen. Cells 
cultured on type IV collagen began to form an epithelium-like 
monolayer at day 8 of culture. These cells expressed pax6 
and cytokeratin 12, both of which are markers of corneal 
epithelial cell differentiation (Liu et al 1994; Moyer et al 
1996). They did not express cytokeratin 14, a marker of 
conjunctival epithelial cells. This suggested that pax6 and 
other signals necessary for the appropriate differentiation of 
corneal epithelial cells from ES cells were provided by their 
interaction with type IV collagen.
Next, we transplanted these cells. After corneal surface 
injury with n-heptanol, these cells were transplanted to 
the injured cornea (Cintron et al 1979; Tsai et al 1990). At 
24 hours after transplantation, histological examination of 
the eyes disclosed that the grafted cells adhered tight to the 
recipient corneal stroma and completely covered the damaged 
corneal surface (Figure 6). We have not noted the develop-
ment of teratoma. We concluded that ES cell-derived epi-
thelial progenitor cells were applicable for corneal epithelial 
cell transplantation.
With our method, approximately 20% of undifferenti-
ated ES cells cultured on type IV collagen differentiated 
into corneal epithelial progenitor cells. This result means 
that the purity of the corneal epithelial cells induced by our 
culture protocol was not satisfactory. To yield puriﬁ  ed cor-
neal epithelial cells, transfer of a gene that promotes corneal 
ES cells
Endoderm Mesoderm Ectoderm
Pancreatic
islet cells
Lung cells
Thyroid cells
Cardiac muscle
Bone
Red blood cells
Tubule cell of
the kidney
Smooth muscle
Corneal
epithelial cells
Skin
Nervous system
Figure 5 Differentiation of ES cells which give rise to several descendants. ES cells are pluripotent, and give rise during development to all derivatives of the three primary 
germ layers: endoderm, mesoderm and ectoderm.Clinical Ophthalmology 2007:1(4) 380
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epithelial cell differentiation into ES cells is a promising 
technology. The pax6 transcription factor is a member of 
the pax gene transcription factor family (Walther and Gruss 
1991) and is known to function during early embryogenesis 
to control key steps in ocular system development (Collin-
son et al 2003). In particular, pax6 is required not only for 
embryonic development but also for postnatal development 
and maintenance of the adult cornea (Davis et al 2003). Pax6 
protein is localized to the nuclei of epithelium, but neither 
stromal nor endothelial cells of the cornea (Koroma et al 1997). 
AB
Corneal stroma
Anterior chamber x400
 ES cell derived
corneal epithelial cells
Figure 6 Transplantation of ES cell-derived corneal epithelial cells onto injured cornea. Mouse cornea was denuded by n-heptanol treatment. ES cell-derived epithelial 
progenitor cells were transplanted to the injured cornea. Histologic analysis was conducted. (A) At 24 hours after transplantation, the eyes were enucleated. Cryostat sec-
tions were stained with hematoxylin and eosin staining. (B) Schematic representation of panel A.
Figure 7 Corneal epithelial progenitor cells differentiated from cynomolgus monkey ES cells in vitro. Inverted microscopic view. ES cells were cultured on cell culture 
dishes for 4 days to form embryoid bodies, and the embryoid bodies were cultured on type IV collagen for 4 more days.  The adhering cells emerged from the embryoid 
bodies had an epithelial cell-like appearance.Clinical Ophthalmology 2007:1(4) 381
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Pax6 has been shown to activate corneal gene promoters for 
cytokeratin 12 (Liu et al 1999; Shiraishi et al 1998); thus, pax6 
is considered a master regulator of eye development.
To obtain highly puriﬁ  ed corneal epithelial cells, we 
introduced the pax6 gene to mouse ES cells (Kayama et 
al 2006). The pax6 gene in combination with green ﬂ  uo-
rescence protein (GFP) and neomycin-resistant gene was 
electrotransfected to ES cells, and the transfected cells were 
cultivated with antibiotic neomycin for 14 days. Neomycin 
selection culture enables us to purify cells which have taken 
up the pax6 gene. After neomycin selection, pax6-transfected 
cells formed a monolayer of cells and demonstrated an epi-
thelial cell-like appearance. We found that the efﬁ  ciency of 
inducing corneal epithelial cells with the pax6 transfection 
method is higher than that by culturing on type IV collagen. 
We then transplanted pax6-transfected cells onto damaged 
cornea (Ueno et al 2006). The pax6-transfected cells formed 
bilayers of epithelial cells that were GFP-positive 24 hours 
after transplantation. The injury-induced detachment of 
corneal epithelial layers caused swelling of the corneal 
stroma, whereas transplantation of pax6-transfected cells 
reduced the swelling and inﬂ  ammatory cell inﬁ  ltration of 
the corneal stroma was subsided. The pax6-transfected cells 
expressed cytokeratin 12 at the grafted site. Contamination 
of other germ cells and teratoma were not detected. Thus, the 
highly puriﬁ  ed corneal epithelial cells derived from pax6-
transfected ES cells survived on the injured cornea. The cells 
restored the damaged cornea histologically and functioned 
as native corneal epithelial cells because they suppressed 
corneal epithelial damage-induced inﬂ  ammation. As the 
next step to clinical application, we have started to culture 
cynomolgus monkey ES cells for the induction of corneal 
epithelial cells. Cynomolgus monkey ES cells share many 
characteristics with human ES cells, and resemble human 
ES cells more than mouse ES cells. Cynomolgus monkey ES 
cells preferentially differentiated into corneal epithelial-like 
cells in vitro (Figure 7).
In summary, we have shown the establishment of corneal 
epithelial cell differentiation of mouse ES cells and cyno-
molgus monkey ES cells. We hope that human ES-derived 
epithelial cells may become applicable for surface reconstruc-
tion of damaged corneas in the near future.
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